Leprecan: Difference between revisions
Jump to navigation
Jump to search
m Task 7c: repair/replace et al. in cs1 author/editor parameters; |
imported>Boghog consistent citation formatting |
||
| Line 18: | Line 18: | ||
|LocusSupplementaryData= | |LocusSupplementaryData= | ||
}} | }} | ||
'''Leprecan''' is a protein associated with [[osteogenesis imperfecta]]<ref name="pmid18566967">{{cite journal | '''Leprecan''' is a protein associated with [[osteogenesis imperfecta]]<ref name="pmid18566967">{{cite journal | vauthors = Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC | display-authors = 6 | title = Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta | journal = Nature Genetics | volume = 39 | issue = 3 | pages = 359–65 | date = March 2007 | pmid = 17277775 | doi = 10.1038/ng1968 }}</ref> type VIII. | ||
==References== | Leprecan is part of a superfamily of 2OG-Fe(II) dioxygenase, along with DNA repair protein AlkB, and disease resistant EGL-9. The enzyme was found to be a type of hydroxylases used in the substrate formation of protein glysosylation.<ref>{{cite journal | vauthors = Aravind L, Koonin EV | title = The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases | journal = Genome Biology | volume = 2 | issue = 3 | pages = RESEARCH0007 | date = 2001-02-19 | pmid = 11276424 | doi = 10.1186/gb-2001-2-3-research0007 }}</ref> | ||
== References == | |||
{{reflist}} | {{reflist}} | ||
==External links== | == External links == | ||
* {{MeshName|leprecan+protein,+human}} | * {{MeshName|leprecan+protein,+human}} | ||
{{biochem-stub}} | {{biochem-stub}} | ||
{{Fibrous proteins}} | {{Fibrous proteins}} | ||
Latest revision as of 21:32, 13 December 2018
| leucine proline-enriched proteoglycan (leprecan) 1 | |
|---|---|
| Identifiers | |
| Symbol | LEPRE1 |
| Entrez | 64175 |
| HUGO | 19316 |
| OMIM | 610339 |
| RefSeq | NM_022356 |
| UniProt | Q32P28 |
| Other data | |
| Locus | Chr. 1 p34.1 |
Leprecan is a protein associated with osteogenesis imperfecta[1] type VIII.
Leprecan is part of a superfamily of 2OG-Fe(II) dioxygenase, along with DNA repair protein AlkB, and disease resistant EGL-9. The enzyme was found to be a type of hydroxylases used in the substrate formation of protein glysosylation.[2]
References
- ↑ Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, et al. (March 2007). "Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta". Nature Genetics. 39 (3): 359–65. doi:10.1038/ng1968. PMID 17277775.
- ↑ Aravind L, Koonin EV (2001-02-19). "The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases". Genome Biology. 2 (3): RESEARCH0007. doi:10.1186/gb-2001-2-3-research0007. PMID 11276424.
External links
- leprecan+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
| Stub icon | This biochemistry article is a stub. You can help Wikipedia by expanding it. |
.svg){kind=link}